S&P 500

5.127,79

1,26%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
RespireRx Pharmaceuticals Inc (PK) (RSPI)
RespireRx Pharmaceuticals Inc (PK) (RSPI) Notícias

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:RSPI

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
02/02/2024	10:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
17/11/2023	18:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
14/11/2023	18:05	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
13/06/2023	17:11	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
22/05/2023	17:17	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
15/05/2023	17:08	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
15/04/2022	15:17	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
31/03/2022	17:11	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
10/01/2022	18:32	Edgar (US Regulatory)	Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
01/12/2021	18:07	Edgar (US Regulatory)	Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
09/08/2021	10:16	Edgar (US Regulatory)	Registration a Offering Under the Securities Act of 1933 (1-a)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
19/02/2021	18:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
30/10/2020	12:19	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
29/10/2020	07:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
20/10/2020	17:31	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
14/10/2020	07:48	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
02/10/2020	16:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
15/09/2020	17:22	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
12/08/2020	14:14	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
04/08/2020	15:16	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
10/04/2020	17:16	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
24/03/2020	14:51	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
20/12/2018	12:32	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
29/06/2018	17:46	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
08/09/2017	09:15	Marketwired	RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
25/08/2017	11:54	Marketwired	RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
14/06/2017	09:45	Marketwired	RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
06/06/2017	18:00	Marketwired	RespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MA	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
10/02/2017	11:30	Marketwired	RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)
06/01/2017	11:15	Marketwired	RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017	USOTC:RSPI	RespireRx Pharmaceuticals Inc (PK)